biomarin.comBioMarin Pharmaceutical Inc.

CompanyLeadership Responsibility Giving Patient Support Science Our Science Research & Development Manufacturing Clinical Trials Publications External Scientific Support Products & Pipeline Overview Products Pipeline Expanded Access Medical Information News Newsroom Stories Press Releases Careers Investors CompanyLeadership Environmental, Social & Governance Diversity, Equity & Inclusion Giving Patient Advocacy Science Products & Pipeline Overview Products Pipeline Medical Information Compassionate Use News Newsroom Stories Press Releases Company Statements Careers InvestorsLocations Contact Locations Contact Search Search BioMarin A 100-Mile Road to Diagnosis: A Mother Shares Her Son’s Journey with Hypochondroplasia Learn more about Benjamin’s experience with hypochondroplasia and how his family is navigating this journey. Read More From Height to Health: Changing the Conversation in Achondroplasia We’re committed to deepening our understanding of achondroplasia and taking a holistic approach to support this community. Read More Where Are They Now? Catching Up with Alumni of Our RARE Scholars Program Get to know some of our past scholarship recipients and learn how the program has supported them in pursuing their career goals. Read More Breakthrough Science We relentlessly pursue bold science to translate genetic discoveries into new medicines that advance the future of human health. Learn More Focus on Patients We listen to and learn from patient communities to collaborate on solutions with the potential to help improve care. Learn More People-First Culture Our talented and dedicated people represent the best the biotech industry has to offer and have helped shape a culture focused on working together to deliver for the patients we serve. Learn More BioMarin is a global biotechnology company with eight marketed products that treat life-threatening conditions. Since our founding in 1997, we’ve applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Our approved medicines treat achondroplasia, severe hemophilia A and several rare inherited and lysosomal storage diseases. We’re also advancing an industry-leading pipeline of investigational medicines that are in various stages of clinical and preclinical development. Learn More Press Releases BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV May 8, 2024 New Data for BioMarin’s VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting May 4, 2024 BioMarin Reports Record Financial Results for the First Quarter 2024 April 24, 2024 BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET April 10, 2024 New Data to be Presented for BioMarin’s VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting March 12, 2024 More News Community Where Are They Now? Catching Up with Alumni of Our RARE Scholars Program April 2, 2024 Community A 100-Mile Road to Diagnosis: A Mother Shares Her Son’s Journey with Hypochondroplasia March 14, 2024 Science From Height to Health: Changing the Conversation in Achondroplasia March 12, 2024 People and Culture Supporting Women at BioMarin: An Interview with the Co-Chairs of Our Women’s Leadership Development Group March 8, 2024 LinkedIn @biomarin In our first year participating in the My Green Labs program, our manufacturing sciences and technology labs in Novato and Shanbally earned top marks with green certification, and one of our quality control labs in Shanbally was certified platinum. Congrats to our teams in Novato and Shanbally for receiving this recognition! View Post Instagram @biomarinpharmaceutical Our longstanding commitment to the PKU community extends beyond medicine and scientific innovation – hear from Olivia Cummings, a neurologist living with PKU, about what it meant to receive financial support during medical school through BioMarin’s RARE Scholars program. View Post Join Our Team Come work with us. Search our global career opportunities to learn how you can make your mark. Explore Opportunities You’re leaving the BioMarin website. Links to sites outside of this website are provided as a resource to the viewer. BioMarin accepts no responsibility for the content of linked sites. Leave this website Close Contact Publication Data Request Report an Adverse Event Reporting a Product Complaint Submit a Medical Information Inquiry Legal Supply Chain Statement Biomarin Data Privacy Center Terms of Use Cookie Settings LinkedIn X Instagram Facebook © 2024 BioMarin. All rights...